UVA Health System frequently opens new clinical trials, offering your patients the latest investigational treatments.
For a complete list of active cancer trials and study coordinator contact information, visit our newly launched Find a Clinical Trial website. If you have patients who may be eligible to participate in a cancer clinical trial, please email cancerclinicaltrials@virginia.edu.
Acute Myeloid Leukemia (IRB-HSR #20233)
A Phase 1 Study of Ipilimumab in Combination with Decitabine in Relapsed or Refractory Myelodysplastic Syndrome/Acute Myeloid Leukemia
Primary Investigator: Michael Keng
Clinical Research Coordinator: Amelia Hodson
Large Granular Lymphocyte Leukemia or Cutaneous T-Cell Lymphoma (IRB-HSR #20347)
A Dose-Ranging Study of Intravenous BNZ132-1-40 in Patients with Large Granular Lymphocyte Leukemia or Cutaneous T-Cell Lymphoma
Principle Investigator: Karen Ballen
Clinical Research Coordinator: Michelle Bailey
Thoracic Oncology (IRB-HSR #19883)
A Phase II Study of Olaparib Plus Cediranib in Combination with Standard Therapy for Small Cell Lung Cancer
Primary Investigator: Richard Hall
Clinical Research Coordinator: Maria Davenport
Graft-Versus-Host Disease (IRB-HSR #20051)
GRAVITAS-301: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Itacitinib or Placebo in Combination With Corticosteroids for the Treatment of First-Line Acute Graft-Versus-Host Disease
Primary Investigator: Leonid Volodin
Clinical Research Coordinator: Michelle Bailey
Melanoma (IRB-HSR #18537)
Low-dose Interleulin-2 and Pembrolizumab Among Patients with Metastatic Melanoma and Renal Cell Carcinoma
Primary Investigator: William Grosh
Clinical Research Coordinator: Alex Carney
GI Oncology (IRB-HSR #20044)
Preeoperative Extended Chemotherapy vs. Chemotherapy Plus Hypofractionated Radiation Therapy for Borderline Resectable Adenocarcinoma of the Head of the Pancreas (NCT02839343)
Primary Investigator: Tri Le
Clinical Research Coordinator: Susan Jones
Metastatic Cervical Cancer (IRB-HSR #20118)
A Phase 2 Study of Atezolizumab (MPDL3280A) in Combination with Bevacizumab in Patients with Recurrent, Persistent or Metastatic Cervical Cancer
Primary Investigator: Leigh Cantrell
Clinical Research Coordinator: Anne Gabel
Hematologic Malignancies (IRB-HSR #20170)
A 2-stage Study of Pracinostat + Azacitidine In Patients With High/Very High Risk of MDS By R-IPSS Who Are Candidates For Azacitidine Treatment
Primary Investigator: Michael Keng
Clinical Research Coordinator: Amelia Hodson
